E-cadherin expression in basal cell carcinoma
1994

E-cadherin Expression in Basal Cell Carcinoma

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): A. Pizarro, N. Benito, P. Navarro, J. Palacios, A. Cano, M. Quintanilla, F. Contreras, C. Gamallo

Primary Institution: Hospital La Paz, Madrid; Instituto de Investigaciones Biomedicas, Consejo Superior de Investigaciones Cientificas, Universidad Autonoma de Madrid, Madrid, Spain.

Hypothesis

E-cadherin might play a role as an invasion-suppressor molecule in basal cell carcinoma.

Conclusion

E-cadherin expression is preserved in superficial and nodular basal cell carcinomas but reduced in infiltrative types, suggesting its role in tumor growth patterns and local aggressiveness.

Supporting Evidence

  • E-cadherin expression was preserved in all specimens of superficial and nodular basal cell carcinoma.
  • E-cadherin expression was reduced in 10 of 15 infiltrative basal cell carcinomas.
  • A heterogeneous distribution of E-cadherin expression was observed in infiltrative basal cell carcinoma specimens.

Takeaway

This study looked at a protein called E-cadherin in skin cancer. It found that this protein helps keep the cancer from growing too aggressively.

Methodology

E-cadherin expression was studied using immunohistochemistry on tissue samples from 31 patients with different types of basal cell carcinoma.

Limitations

The study had a small sample size and did not analyze the correlation between E-cadherin expression and anatomical site due to diversity in tumor locations.

Participant Demographics

Patients included 31 individuals with basal cell carcinoma, with varying ages and sex.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication